[go: up one dir, main page]

PL357999A1 - Nowi antagoniści LHRH, ich wytwarzanie i zastosowanie jako środka leczniczego - Google Patents

Nowi antagoniści LHRH, ich wytwarzanie i zastosowanie jako środka leczniczego

Info

Publication number
PL357999A1
PL357999A1 PL01357999A PL35799901A PL357999A1 PL 357999 A1 PL357999 A1 PL 357999A1 PL 01357999 A PL01357999 A PL 01357999A PL 35799901 A PL35799901 A PL 35799901A PL 357999 A1 PL357999 A1 PL 357999A1
Authority
PL
Poland
Prior art keywords
lhrh
antagonists
medicament
production
hormone
Prior art date
Application number
PL01357999A
Other languages
English (en)
Inventor
Michael Bernd
Bernhard Kutscher
Eckhard Gunther
Peter Romeis
Thomas Reissmann
Thomas Beckers
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/525,007 external-priority patent/US6627609B1/en
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of PL357999A1 publication Critical patent/PL357999A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL01357999A 2000-03-14 2001-03-12 Nowi antagoniści LHRH, ich wytwarzanie i zastosowanie jako środka leczniczego PL357999A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/525,007 US6627609B1 (en) 1999-03-17 2000-03-14 LHRH antagonists having improved solubility properties
PCT/EP2001/002719 WO2001068676A2 (de) 2000-03-14 2001-03-12 Lh-rh-antagonisten, deren herstellung und verwendung als arzeimittel

Publications (1)

Publication Number Publication Date
PL357999A1 true PL357999A1 (pl) 2004-08-09

Family

ID=24091545

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01357999A PL357999A1 (pl) 2000-03-14 2001-03-12 Nowi antagoniści LHRH, ich wytwarzanie i zastosowanie jako środka leczniczego

Country Status (25)

Country Link
EP (1) EP1268522B1 (pl)
JP (1) JP3805679B2 (pl)
KR (1) KR100607396B1 (pl)
CN (2) CN1443195A (pl)
AT (1) ATE408619T1 (pl)
AU (2) AU6011001A (pl)
BG (1) BG107121A (pl)
BR (1) BR0109279A (pl)
CA (1) CA2402193C (pl)
DE (1) DE50114335D1 (pl)
DK (1) DK1268522T3 (pl)
ES (1) ES2312435T3 (pl)
HR (1) HRP20020810A2 (pl)
HU (1) HUP0300222A3 (pl)
IL (1) IL151647A0 (pl)
MX (1) MXPA02008870A (pl)
NO (1) NO20024363L (pl)
NZ (1) NZ521273A (pl)
PL (1) PL357999A1 (pl)
PT (1) PT1268522E (pl)
RU (1) RU2248982C9 (pl)
SK (1) SK14332002A3 (pl)
UA (1) UA79070C2 (pl)
WO (1) WO2001068676A2 (pl)
ZA (1) ZA200207248B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100340572C (zh) * 2004-12-01 2007-10-03 中国人民解放军军事医学科学院毒物药物研究所 新的lhrh拮抗剂
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
EP2252627B1 (en) 2008-01-24 2017-04-19 Esperance Pharmaceuticals Lytic domain fusion constructs and methods of making and using same
CN101597321B (zh) * 2008-06-03 2013-04-24 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
WO2010142060A1 (zh) * 2009-06-11 2010-12-16 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
AU2013337926B2 (en) 2012-10-30 2017-12-21 Esperance Pharmaceuticals, Inc. Antibody/drug conjugates and methods of use
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途
FR3024612B1 (fr) * 2014-08-04 2018-03-09 Alstom Transp Tech Module d'alimentation electrique d'un bloc moteur, systeme de traction et vehicule electrique associe
RU2585367C1 (ru) * 2014-11-05 2016-05-27 Наталья Владимировна Спиридонова Способ лечения бесплодия у женщин с миомой матки

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110904A (en) 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5140009A (en) 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5300492A (en) 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
IL101074A (en) 1991-03-14 1997-09-30 Salk Inst For Biological Studi GnRH ANALOGS AND THEIR PREPARATION
DE593491T1 (de) 1991-04-25 1994-11-17 Romano S.-Cergue Deghenghi LHRH-Antagonisten.
EP0673254A4 (en) 1992-12-04 1998-11-18 Abbott Lab HORMONE ANTAGONISTS RELEASING LUTEINIZING HORMONE (LHRH) OF MODIFIED DECAPEPTIDES IN POSITION 6.
EP0683792B1 (en) 1992-12-18 2001-09-26 Abbott Laboratories Lhrh antagonists having modified aminoacyl residues at postions 5 and 6
IL108509A0 (en) 1993-02-22 1994-05-30 Salk Inst For Biological Studi GnRH antagonist peptides
DE4320201A1 (de) * 1993-06-18 1995-01-12 Asta Medica Ag Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation
DE19544212A1 (de) 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
DE19911771B4 (de) 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
CN100500692C (zh) 2009-06-17
AU2001260110B2 (en) 2005-05-05
PT1268522E (pt) 2008-12-22
CN1443195A (zh) 2003-09-17
HUP0300222A2 (hu) 2003-07-28
EP1268522B1 (de) 2008-09-17
JP2003535044A (ja) 2003-11-25
BG107121A (bg) 2003-05-30
CA2402193A1 (en) 2002-09-09
BR0109279A (pt) 2002-12-17
IL151647A0 (en) 2003-04-10
KR20020083179A (ko) 2002-11-01
EP1268522A2 (de) 2003-01-02
WO2001068676A2 (de) 2001-09-20
JP3805679B2 (ja) 2006-08-02
HUP0300222A3 (en) 2004-08-30
DE50114335D1 (de) 2008-10-30
UA79070C2 (en) 2007-05-25
HRP20020810A2 (en) 2004-12-31
NO20024363L (no) 2002-11-13
RU2248982C2 (ru) 2005-03-27
CA2402193C (en) 2010-05-18
RU2248982C9 (ru) 2005-06-10
NO20024363D0 (no) 2002-09-12
DK1268522T3 (da) 2009-01-12
CN1876677A (zh) 2006-12-13
ZA200207248B (en) 2003-02-21
WO2001068676A3 (de) 2002-10-24
KR100607396B1 (ko) 2006-08-02
ATE408619T1 (de) 2008-10-15
MXPA02008870A (es) 2003-06-24
ES2312435T3 (es) 2009-03-01
NZ521273A (en) 2005-01-28
AU6011001A (en) 2001-09-24
SK14332002A3 (sk) 2003-09-11

Similar Documents

Publication Publication Date Title
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
SE0001899D0 (sv) New compounds
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
HUP0401534A2 (hu) Módosított humán IX. faktor
NO20015584L (no) Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
PL364598A1 (pl) Stabilna odmiana polimorficzna flibanseryny, techniczny sposób jej wytwarzania i jej zastosowanie do otrzymywania leków
AU2001264515A1 (en) Melphalan derivatives and their use as cancer chemotherapeutic drugs
IL159993A0 (en) Platinum complexes and their use in cancer treatment
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
PL357999A1 (pl) Nowi antagoniści LHRH, ich wytwarzanie i zastosowanie jako środka leczniczego
UA72927C2 (uk) Композиція для лікування печінково-клітинного раку, що містить доцетаксель
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
TW200531717A (en) Vinflunine pharmaceutical composition for parenteral administration, preparation process and use thereof
HK1068606A1 (en) Novel aminobenzoephenones
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
AU3739500A (en) Protease resistant flint analogs
MY138219A (en) Biologically active peptides
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
GB0128071D0 (en) Medicament
WO2004078761A8 (en) Enantiomerically pure cilazapril,process for preparation
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS
MXPA04000918A (es) Pramipexol como anticonvulsivo.

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)